您的位置: 首页 > 农业专利 > 详情页

SEL PHARMACEUTIQUE D'UN COMPOSÉ IMIDAZOLE HÉTÉROCYCLIQUE ANTITUMORAL
专利权人:
Shanghai Huilun Life Science & Technology Co.; Ltd
发明人:
申请号:
EP17859727.4
公开号:
EP3527566A1
申请日:
2017.10.11
申请国别(地区):
EP
年份:
2019
代理人:
摘要:
The present invention relates to the field of pharmaceutical synthesis, and in particular to an antitumor heterocyclic imidazole compound (I), namely: a pharmaceutical salt of 4-(3-(4-(1H-imidazo[4,5-b]pyridine-5-yl)piperazine-1-carbonyl)-4-fluorobenzyl)phthalazin e-1(dihydro)-ketone, a preparation method therefore, a pharmaceutical composition thereof and a use thereof in the preparation of antitumor drugs. The pharmaceutical salt of the compound (I) in the present invention may be used in the preparation of a medicament for the treatment or prevention of conditions which can be improved by inhibiting PARP activity.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充